PMC9524245_01
Direct Immunofluorescence consistent with Bullous Pemphigoid Diagnosis.
fimmu-13-984132-g001.jpg
PMC9524245_01_fimmu-13-984132-g001.jpg
f1
In October 2020, as systemic corticosteroids had been decreased to 10 mg per day, the patient presented new pruriginous skin lesions associated with cutaneous blisters, which biopsy and direct immunofluorescence revealed a junctional bullous auto-immune dermatitis, concordant with the BP diagnosis that had previously been established ( Figure 1 ).
Diagnosis and Treatments Timeline.
fimmu-13-984132-g002.jpg
PMC9524245_01_fimmu-13-984132-g002.jpg
f2
BP is relatively controlled by Methotrexate, even if he still presents pruritis than requires prolonged symptomatic treatment ( Figure 2 ).